Liza Akhvledziani Carew, Co-Founder and CEO of Chexy, is fixing one of the most overlooked corners of fintech, rent payments. A system millions of Canadians rely on every month, that's been broken for decades.

She set out to change that. And the result? Chexy just surpassed $1B in annual run-rate payment volume, making it one of Canada's fastest-growing payment platforms. Not by chasing the obvious opportunity, by going deep on a problem nobody else was paying attention to.

What to expect:

• How to spot billion-dollar problems hiding in plain sight: Learn how Liza identified a massive opportunity in an overlooked, everyday friction point, and what it took to act on it.

• What it really takes to build fintech in Canada: No big bank behind her. No existing playbook. Hear how she navigated the payments industry from the ground up.

• The grit behind the milestone: $1B is the headline. Hear what came before it.

Anthony Mouchantaf, Co-Founder and CEO of Biossil, is solving a problem hiding inside drug discovery's biggest failure: thousands of safe, effective drugs never reach patients, not because they don't work, but because they were tested on the wrong populations.

The insight: the $100B+ drug discovery industry doesn't need more new drugs. It needs to find the right patients for the ones it already has. Their AI platform synthesizes over a trillion data points to advance phase 2 and 3-ready drugs to market, faster and cheaper. 11 active programs. Backed by Staircase Ventures, Founders Fund, and OpenAI.

What to expect:

• How to find the blind spot in your industry: Hear how Anthony identified a massive opportunity inside a broken system, and how you can apply the same thinking to your own space.

• How to build as a non-traditional founder: A lawyer with no biotech background built one of Canada's most exciting AI biopharma companies. Here's how.

• How to use AI to do what wasn't possible before: Not to automate, to unlock an entirely new category. Biossil is proof.

Toronto's best builders gather once a year. April 13 is that night.

Best Of, a room full of Toronto's best builders, celebrating the milestones that move the whole community forward. Doors open at 6pm, stories start at 7pm, and the afterparty runs until the last conversation ends.

Early bird tickets are live, and they won't last long.

Last month, a room full of health tech founders gathered at OneEleven for Health Toronto. What came out of it? Exactly what you'd expect from TechTO: raw numbers, real stories, and advice you can actually use.

The number that should bother every health founder in Canada.

Dr. Ivan Cacic didn't come with a pitch deck. He came with a diagnosis.

Canada spends more on healthcare than almost any OECD nation. The return? Worst wait times, worst outcomes, a system so buried in chronic disease management there's nothing left for prevention.

His fix: Stop reacting. Start predicting.

ProMed AI runs 24/7 - pulling lab results, monitoring vitals, flagging risk before the crisis hits. Not replacing clinical judgment, but yes, extending it.

The credibility check: ProMed AI is one of 11 companies globally licensed to train on Mayo Clinic's deidentified data.

Mary Aglipay's health tech story didn't start at a hospital. It started in a laundry room.

No software engineers, no VC war chest, just one problem they couldn't shake: family doctors drowning in paperwork while patients waited longer to be seen.

Eighteen months after launch, Pippen AI is inside 1,200 family doctors' offices across Canada. That's nearly 3% of all family physicians in the country.

How? They picked one problem - physician admin overload - and didn't move until they had undeniable traction. You don't need to change behaviour, you need to reduce friction inside what doctors already do. Pippen AI found that lane and ran.

Anne Forsyth has spent 15 years inside the healthcare bureaucracy. Provincial government, Federal organizations, and now Director of Clinical Applications at Women's College Hospital. She's never done a product pitch, but she's the person on the other side.

At Health Toronto, she explained why solid technology stalls inside hospital systems. The short answer? It's almost never the product.

This fireside chat had three voices worth hearing.

Olga Cruz (Director, Thrive Lab at BDC Capital) - the investor. Katie Herbert - the founder building Healthkind, a patient communications platform. Matt Zukowski - the technical co-founder who previously built Akira and sold it to TELUS.

What separates health tech that lasts from health tech that dies?

Their answer wasn't a framework. It was a sequence:

1. Be obsessed, not motivated. 

2. Patient communications is the foundation. 

3. Use AI to do the impossible, not the replaceable. 

4. Trust beats speed. 

Don’t forget to lock in your year of TechTO! Subscribe to our full events calendar

Our Directory helps you find the community's favourite service providers, vetted and backed by TechTO. A few perks worth grabbing this week:

• Leaving R&D tax credits on the table? Boast helps Canadian and US companies claim every dollar they're owed, with AI-powered tracking and in-house tax experts to minimize audit risk. TechTO members get 10% off their first-year R&D Tax Credit application + a free SR&ED Tech Scoping Assessment (no prep needed, no cost). Email Carlos at [email protected] with subject line: Referral from TechTO - TechTO Member - Book your free assessment

• Looking for stylish swag that actually impresses? Wayo makes custom merch at factory-direct prices, powered by AI - browse, customize, and check out instantly. TechTO community gets 10% off their first order - Claim the offer here